NASDAQ
Dyne Therapeutics, Inc. (DYN) has a price/fcf ratio of -6.20x as of Monday, May 25, 2026. This represents a 21.09% decrease compared to its 12-month average of -5.12x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.